are there natural glp 1 agonists GLP-1 receptor for individualized treatment of type 2 diabetes mellitus GLP-1 Receptor Agonists in Solid
Description
That uncertainty is understandable
CJC-1131, a long acting GLP-1 analog, safely normalizes post-prandial glucose excursion and fasting glycemia in type 2 diabetes mellitus [abstract]
It consists of five categories: (1) bias arising from the randomized process, (2) bias due to deviations from intended interventions, (3) bias caused by missing outcome data, (4) bias in the measure of outcome, and (5) bias in the selection of the reported result
J Endocrinol (2014) 221(1):T3141
The results were clear
Grech O, Mollan SP, Wakerley BR, Alimajstorovic Z, Lavery GG, Sinclair AJ
